Research Areas

In this section, by  far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.

14 Item(s)

per page
Axon ID Name Description From price
3946 Altiratinib Balanced inhibitor for MET, TIE2 (TEK), and VEGFR2 (KDR) kinases Inquire
1916 AMG 208 Inhibitor of c-MET receptor tyrosine kinase (RTK) €95.00
3945 AMG-337 Potent and exquisitely selective inhibitor of wild-type and some mutant forms of c-Met Inquire
1838 ARQ 197 c-MET tyrosine kinase Inhibitor €90.00
4040 BMS-777607 potent, selective and orally bioavailable c-Met inhibitor Inquire
3423 Capmatinib Highly potent, selective, ATP competitive and orally bioavailable c-MET inhibitor €80.00
1660 Crizotinib c-MET Inhibitor; NPM-ALK inhibitor €70.00
1582 Foretinib c-MET and VEGFR2 tyrosine kinase inhibitor €90.00
2553 LY 2801653 Orally bioavailable multi-kinase inhibitor with potent activity against c-MET €120.00
3975 MGCD265 dihydrochloride Orally active, potent MET/SMO dual inhibitor €130.00
1583 PF 04217903 mesylate c-MET tyrosine kinase Inhibitor €80.00
1914 SGX 523 ATP-competitive inhibitor of c-MET €120.00
1581 SU 11274 ATP-competitive inhibitor of c-MET €90.00
3864 Volitinib dihydrochloride ATP-competitive small molecule c-Met kinase inhibitor Inquire

14 Item(s)

per page
Please wait...